Identification of Cx43 variants predisposing to ventricular fibrillation in the acute phase of ST-elevation myocardial infarction
Open Access
- 9 August 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (1) , 101-111
Abstract
Ventricular fibrillation (VF) occurring in the acute phase of ST-elevation myocardial infarction (STEMI) is the leading cause of sudden cardiac death worldwide. Several studies showed that reduced connexin 43 (Cx43) expression and reduced conduction velocity increase the risk of VF in acute myocardial infarction (MI). Furthermore, genetic background might predispose individuals to primary VF (PVF). The primary objective was to evaluate the presence of GJA1 variants in STEMI patients. The secondary objective was to evaluate the arrhythmogenic impact of GJA1 variants in STEMI patients with VF. The MAP-IDM prospective cohort study included 966 STEMI patients and was designed to identify genetic predisposition to VF. A total of 483 (50.0%) STEMI patients with PVF were included. The presence of GJA1 variants increased the risk of VF in STEMI patients [from 49.1 to 70.8%, P = 0.0423; odds ratio (OR): 0.40; 95% confidence interval: 0.16–0.97; P = 0.04]. The risk of PVF decreased with beta-blocker intake (from 53.5 to 44.8%, P = 0.0085), atrial fibrillation (from 50.7 to 26.4%, P = 0.0022), and with left ventricular ejection fraction >50% (from 60.2 to 41.4%, P < 0.0001). Among 16 GJA1 variants, three novel heterozygous missense variants were identified in three patients: V236I, H248R, and I327M. In vitro studies of these variants showed altered Cx43 localization and decreased cellular communication, mainly during acidosis. Connexin 43 variants are associated with increased VF susceptibility in STEMI patients. Restoring Cx43 function may be a potential therapeutic target to prevent PVF in patients with acute MI. Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT00859300Keywords
Funding Information
- Medtronic and Abbott
- AFM-telethon and Fond Marion Elisabeth Brancher
This publication has 27 references indexed in Scilit:
- Genetic predisposition for sudden cardiac death in myocardial ischaemia: the Arrhythmia Genetics in the NEtherlandS studyNetherlands Heart Journal, 2011
- Relationship Between Nonsustained Ventricular Tachycardia After Non–ST-Elevation Acute Coronary Syndrome and Sudden Cardiac DeathCirculation, 2010
- Paradigm of Genetic Mosaicism and Lone Atrial FibrillationCirculation, 2010
- Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarctionNature Genetics, 2010
- Cardiac Connections — The Antiarrhythmic Solution?New England Journal of Medicine, 2008
- Family History and the Risk of Sudden Cardiac Death as a Manifestation of an Acute Coronary EventCirculation, 2006
- Acute ischemia-induced gap junctional uncoupling and arrhythmogenesisCardiovascular Research, 2004
- Connexin 43 (GJA1) Mutations Cause the Pleiotropic Phenotype of Oculodentodigital DysplasiaThe American Journal of Human Genetics, 2003
- Predicting Sudden Death in the PopulationCirculation, 1999
- Sudden Cardiac DeathCirculation, 1998